MedTrace Logo

Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy

NCT00558584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of immunoadsorption and subsequent IgG substitution in patients with dilated cardiomyopathy compared to a control group.

Conditions

  • Dilated Cardiomyopathy

Interventions

DEVICE

protein A immunoadsorption

protein-A immunoadsorption and i.v. IgG substitution

DEVICE

pseudo-immunoadsorption

pseudo-immunoadsorption followed by an intravenous infusion without IgG

Sponsors & Collaborators

  • Krupp von Bohlen und Halbach-Foundation, Essen, Germany

    collaborator UNKNOWN

  • ENDI-Foundation, Bad Homburg, Germany

    collaborator UNKNOWN

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Stephan B Felix, MD · Ernst-Moritz-Arndt University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2021-09-30
Completion
2023-04-30

Countries

  • Germany
  • Serbia
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00558584 on ClinicalTrials.gov